- CA$75.53m
- CA$50.04m
Brief: Willow Signs Master Services Agreement With Innovative Biotech Company To Develop Ingredients For Age-Related Diseases
Brief: Kalsec And Willow Biosciences To Develop Novel Enzyme For Production Of An Advanced Beverage Ingredient
Brief: Willow Announces Commercial Agreement With Sandhill One
Brief: Willow Announces Rollout Of Biooxi Platform Providing Valuable And Expedited Bioconversion-Enabled Chemical Manufacturing
Brief: Willow Biosciences Promotes Chris Savile to CEO
Brief: Willow Appoints Jim Lalonde To Board Of Directors
Brief: Willow Announces Follow-On Engagement For Next Phase Of Partnered Pharma Project
Brief: Willow Biosciences Inc- Company Is Well Positioned To Pursue Its Next Targeted Milestones For 2023
Brief: Willow Optimizes To Focus On Near-Term Revenue Generation, Reduce Cash Burn
Brief: Kalsec Signs Agreement With Willow Biosciences For Functional Food Ingredients
Brief: Willow Biosciences Provides CBG Update
Brief: Willow Biosciences Reports Second Quarter 2022 Results
Brief: Willow Biosciences Appoints Dr. Peter Seufer-Wasserthal As Interim President And CEO
Brief: Willow Biosciences Incorporates Inscripta's Onyx Platform
Brief: Willow Biosciences Reports First Quarter 2022 Results
Brief: Willow Biosciences Publishes First Peer Reviewed Article Demonstrating Clinical Benefit Of CBG For Skincare
Brief: Willow Biosciences Reports Third Quarter 2021 Results
Brief: Willow Biosciences Announces Commercial Scale Operational Update, CBGA Production Update, Corporate Update
Brief: Willow Biosciences And Cellular Goods Announce Multiyear Supply Agreement For Cannabigerol